ArticleBiomedicines2023

Esaxerenone Protects against Diabetic Cardiomyopathy via Inhibition of the Chemokine and PI3K-Akt Signaling Pathway.

Ziyue Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.